businessman investment consultant analyzing company financial report balance sheet statement working with digital graphs. Concept picture for stock market, office, tax,and project. 3D illustration. istock photo for BL | Photo Credit: iStockphoto
Q4 Results Today, May 5, 2026, Live Updates: Find all the latest Q4 results 2026 updates of Aadhar Housing Finance, AAVAS Financiers, Automobile Corporation of Goa, Aeroflex Industries, Ajanta Pharma, Cigniti Technologies, Coforge, Dalmia Bharat Sugar and Industries, DCW, Gravity India, Hero MotoCorp, Integra Switchgear, Larsen & Toubro, Mahindra & Mahindra, Mafatlal Industries, Marico, Onward Technologies, Punjab National Bank, Poonawalla Fincorp, Spandana Sphoorty Financial, SRF, United Breweries, and Voltamp Transformers.
Ambuja Cements, BHEL, Tata Tech, Aditya Birla Capital, Godrej Prop, CAMS, Exide, Ather, Quess Corp and more in focus
Stay tuned for more updates from businessline
FILTERS UPDATES
- May 5, 2026 09:29
Stock up
BHEL Q4 results live: Shares soar
BHEL shares soared 3% in early trade to Rs 387.65, from the previous close of Rs 377.05.
The stock hit a 52-week high of Rs 399 in previous trading session following more than 2.5 times jump in consolidated net profit in the quarter ended March 2026.
- May 5, 2026 09:26
Stock down
Ambuja Cements Q4 results live: Shares down
Ambuja Cements stock declined 3% to Rs 432.30 in early trade from the previous close of Rs 445.30. Company reported a 78.5 per cent year-on-year jump in consolidated net profit to ₹1,830 crore for the fourth quarter of FY26
- May 5, 2026 09:24
Quarterly results
Jyothy Labs Q4 results live:
FMCG firm Jyothy Labs Ltd on Monday reported a 12.3 per cent decline in its net profit to ₹67.5 crore in the March quarter of FY’26, on a year-on-year basis.
It had posted a consolidated net profit of ₹77 crore in the January-March quarter a year ago, according to a regulatory filing by Jyothy Labs, which owns brands such as Ujala, Pril, Margo and Exo.
- May 5, 2026 09:22
Stock market
Stock market live, Q4 results live: Top Nifty 50 movers
Top gainers of Nifty 50: Infosys (+1.05%), TCS (+0.88%), ITC (+0.64%), HUL (+0.58%), Wipro (+0.53%)
Top losers: Shriram Finance (-1.53%), Maruti (-1.27%), Bajaj Finance (-1.19%), HDFC Bank (-0.89%), Bajaj Finserv (-0.87%)
- May 5, 2026 09:20
Quarterly results
Suryoday Small Finance Bank Q4 results live:
Suryoday Small Finance Bank Offers Savings Account Interest Rates up to 7.60% p.a
Monday, 04 May 2026: Suryoday Small Finance Bank (SSFB) has announced a revision in its Fixed Deposit (FD) interest rates effective 01 May 2026, offering customers attractive returns across multiple balance slabs for Domestic, NRE and NRO savings accounts.
With the revised structure, customers maintaining higher account balances can now earn up to 7.60% per annum, making Suryoday Small Finance Bank one of the leading banks offering competitive savings account returns. The revised rates are designed to provide customers with competitive and stable investment options while continuing the bank’s promise to help customers “Save More. Earn More. Smile More.”
Key highlights of the revised FD rates include:
7.60% p.a. on balances above ₹5 crore up to ₹25 crore
7.50% p.a. on balances above ₹25 lakh up to ₹5 crore
6.50% p.a. on balances above ₹10 lakh up to ₹25 lakh
5.50% p.a. on balances above ₹5 lakh up to ₹10 lakh
Applicable across Domestic, NRE and NRO Savings Accounts
- May 5, 2026 09:19
Stock market
Stock market live, Q4 results live: Sensex, Nifty 50 dip
Sensex traded 246.49 pts or 0.32% lower at 77,022.91 at 9.17 am after opening at 77,103.72 from the previous close of 77,269.40, and Nifty 50 dipped 91.95 pts or 0.38% to 24,027.35.
- May 5, 2026 09:15
ACUTAAS CHEMICALS
ACUTAAS CHEMICALS – CONCALL HIGHLIGHTS
Battery Chemicals Expansion
- Phase1 capex completed at Jhagadia
- 2000MT capacity for VC and FEC
- Fully tied with 3-year contracts
- Production already commenced
- Revenue ramp through FY27
- Phase2 capex by Q1FY27
- Third product capex ongoing
- Two new products planned FY27
CDMO Pipeline
- 4 products validated commercially
- Under regulatory approval stage
- ₹50–100Cr peak revenue each
- Ramp-up expected by FY28
- 10-year supply contract secured
- Strong global client relationship
Growth Outlook
- FY27 revenue growth ~25%
- Consistent decade-long track record
- Three growth engines driving business
- Pharma CDMO largest contributor
- Battery chemicals ramping up
- Semiconductor recovery underway
Margins & Capex
- EBITDA margin ~34.5–35%
- FY27 capex ~₹90Cr planned
- Includes spillover and maintenance
- R&D expansion under consideration
R&D Expansion
- 10x capacity expansion planned
- Multi-sector R&D capabilities
- Pharma, battery, semiconductor focus
- Long-term innovation pipeline
Management Commentary
- Battery and semi become key engines
- Independent growth by FY28 expected
- CDMO ramp steep post commercialization
- Sustained growth visibility
Final Takeaway
- Strong multi-engine growth model
- High-margin specialty chemicals focus
- Execution key for next phase
Disclaimer
- Not a buy/sell recommendation
- May 5, 2026 09:13
Quarterly results
Ambuja Cements’ Q4 live: profit jumps 79% to ₹1,830 crore; sees cost pressures ahead
Ambuja Cements Q4 Results: Profit jumps 79% to ₹1,830 cr; cost pressures ahead
Ambuja Cements reports a 79% profit surge in Q4 FY26, but anticipates ongoing cost pressures impacting future growth.
Published on May 5, 2026
